Sep 22, 2021
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
Read More
Sep 2, 2021
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Read More
Sep 1, 2021
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
Read More
Aug 25, 2021
Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
Read More
Jul 19, 2021
Renovacor Announces the Appointment of Elizabeth White, Ph.D., as Chief Business Officer and Senior Vice President of Operations
Read More
Jul 15, 2021
Antag Therapeutics appoints Dr. Christine T. Fischette to its Board of Directors
Read More